BRCA Panel Testing at DNA GTx uses advanced genomic sequencing to detect both inherited (germline) and acquired (somatic) mutations in BRCA1 and BRCA2 genes. These insights are essential for targeted treatment decisions for breast, ovarian, prostate, and related cancers. With precise and comprehensive analysis, we empower patients and clinicians to pursue early intervention, personalized prevention, and optimized therapy strategies.
The BRCA Panel analyzes BRCA1 and BRCA2 genes to detect germline and somatic mutations linked to increased risk of breast, ovarian, and prostate cancer, helping guide prevention and treatment strategies.
The BRCA 1/2 Panel analyzes germline mutations in BRCA1 and BRCA2, key genes linked to hereditary breast, ovarian, prostate, and related cancers. This focused test helps identify inherited cancer predisposition, guiding early detection, prevention, and personalized care strategies.
The BRCA Plus Panel expands beyond BRCA1 and BRCA2 to include additional genes associated with hereditary and acquired cancer risk. It detects both germline and somatic variants, providing a comprehensive view needed for precision oncology and treatment planning.
Let’s Decode the Future of Health — Together
Get in touch today — let’s start a conversation that could change lives
*All information is handled with strict confidentiality.
Find Answers Today
Early detection saves lives
*All information is handled with strict confidentiality.